¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

±¹¸³¾Ï¼¾ÅÍ 2023 Updates for Colorectal Cancer Guidelines & Trials : 2023-07-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

±¹¸³¾Ï¼¾ÅÍ 2023 Updates for Colorectal Cancer Guidelines & Trials : 2023-07-15
±³À°ÀÏÀÚ : 2023-07-15
±³À°Àå¼Ò : ±¹¸³¾Ï¼¾ÅÍ °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀǽÇ

±³À°ÁÖÁ¦ : 2023 Updates for Colorectal Cancer Guidelines & Trials

ÁÖÃÖ±â°ü : ±¹¸³¾Ï¼¾ÅÍ
´ã´çÀÚ : À¯±âÈ£
¿¬¶ôó : 010-8547-7995  

À̸ÞÀÏ : risingkyo@ncc.re.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 09:00~09:15 Guidelines - Review & Evidences Surveillance in genetic and familial high-risk group Kim Bun(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 09:15~09:35 Trials – AI for polyp detection during colonoscopy: A proposal for a collaborative research SEKIGUCHI Masau(National cancer center Japan)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 09:35~09:50 Trials – Long-term survival results of high-risk T1 CRC: Surgery versus endoscopic resection Han Kyung Su(±¹¸³¾Ï¼¾ÅÍ)

Åä·Ð 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 09:50~10:10 Åä·Ð ( )

ÈÞ½Ä 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 10:10~10:25 ÈÞ½Ä ( )

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 10:25~10:40 Guidelines - Review & Evidences Choi Moon ki(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 10:40~10:55 Trials - Plasma study of circulating tumor DNA directed adjuvantchemotherapy in colon cancer (CLAUDIA trial) Cha Yong Jun(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 10:55~11:10 Trials - Total neoadjuvant therapy with short-course radiotherapy versus long-course neoadjuvant chemoradiotherapy in locally advanced rectal cancer (TV-LARK) Kim Min Jung(¼­¿ï´ëÇб³º´¿ø)

Åä·Ð 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 11:10~11:30 Åä·Ð ( )

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 11:30~12:00 Latest Colorectal Cancer Treatment Guidelines and JCOG ColorectalCancer Study Group Update KANEMITSU Yukihide(National Cancer Center Japan)

½Ä»ç 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 12:00~13:00 ½Ä»ç ( )

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 13:00~13:15 Trials - Updates on surgical treatment for peritoneal metastasis PARK Eun Jung(¿¬¼¼´ëÇб³º´¿ø)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 13:15~13:30 Trials - Lymphatic drainage pattern using fluorescence lymph node mapping for laparoscopic right hemicolectomy SON Gyung Mo(ºÎ»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 13:30~13:45 Trials - Low anterior resection syndrome RYOO Seung Bum(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 13:45~14:00 Trials - Minimally invasive surgery for liver metastasis of CRC KIM Ji Hoon(±¹¸³¾Ï¼¾ÅÍ)

Åä·Ð 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 14:00~14:20 Åä·Ð ( )

ÈÞ½Ä 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 14:20~14:35 ÈÞ½Ä ( )

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 14:35~14:50 Guidelines - Review & Evidences YOO Ki Ho(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 14:50~15:10 Trials - Revisiting the question of lateral lymph node dissection versus chemoradiotherapy in lower rectal cancer - a proposal for a collaborative research NAGATA Hiroshi(National Cancer Center Japan)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 15:10~15:30 Trials - Robotic Surgery for Colorectal Cancer - Current situation in NCCH Japan TSUKAMOTO Shunsuke(National Cancer Center Japan)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 15:30~15:45 Trials - Comparison of laparoscopic versus robot-assisted surgery for rectal cancers (The COLARAR Randomized Controlled Trial) (Kyungpook National University) PARK Jun Seok(°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 15:45~16:00 Trials - A randomized clinical trial comparing transanal and traditional laparoscopic TME for rectal cancer (COLOR III Trial) PARK Sung Chan(±¹¸³¾Ï¼¾ÅÍ)

Åä·Ð 07¿ù 15ÀÏ ±¹Á¦È¸ÀÇÀå 16:00~16:30 Åä·Ð ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ±¹¸³¾Ï¼¾ÅÍ 2023 Updates for Colorectal Cancer Guidelines & Trials : 2023-07-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ â¿ø ½ÉÆ÷Áö¾ö : 2023-07-15
´ÙÀ½±Û ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦2ȸ ÇÚÁî¿Â ¿öÅ©¼ó 1ºÎ : 2023-07-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 22 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 23 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 30 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 27 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 24 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 13 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 6 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 13 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 5 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 17 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 9 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 15 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 12 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷